Preclinical safety, pharmacology and toxicology studies are an essential part of drug development, as they help assess the potential safety and toxicity of a candidate-drug before it is tested in human clinical trials. Good Laboratory Practice (GLP) is a system of...
ETISENSE and ERBC have jointly organized a webinar on January 30, co-hosted by Timothé FLENET, CEO and Scientific Director of ETISENSE and Raafat FARES, Scientific Director of ERBC. This replay is the opportunity to learn more about the way we can support your...
Marmoset (a small size NHP): Incorporation of safety pharmacology endpoints in toxicology studiesRaafat Fares and Pascal Champéroux European Research Biology Center (ERBC), Baugy, France Safety Pharmacology Society Annual Meeting, 2023 Abstract The common marmoset...
Non-Invasive Monitoring Of Cardiac Output: Validation In Anesthetized Laboratory Rats By Pharmacological Beta-Adrenergic Pathway ModulationLeandro Fontana Pires1,2, Agathe Cambier2, Stéphane Tanguy1, Charles Eynard2, Timothé Flenet2, Pierre-Yves Gumery1, François...
Etisense will attend the Safety Pharmacology Society 2023 Annual MeetingVisit Etisense at the SPS 2023 Annual Meeting, on September 18-21 at the Square Brussels Meeting Center in Brussels (Belgium), at booth #507. This meeting will be the opportunity to know more...
"Comment la recherche médicale réduit l’expérimentation animale"Retrouvez Etisense et sa solution non-invasive DECRO dans Le Figaro du 25 août 2023. Les laboratoires sont en quête d'alternatives technologiques, sans pouvoir à ce stade se passer de tests sur les...